Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.350
+0.250 (8.06%)
At close: Mar 9, 2026, 4:00 PM EDT
3.390
+0.040 (1.19%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Galectin Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -37.3 | -47.05 | -41.07 | -38.78 | -30.53 | -23.47 | |
| Depreciation & Amortization | 0.02 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Stock-Based Compensation | 2.05 | 2.45 | 2.26 | 2.87 | 2.08 | 1.8 | |
| Other Operating Activities | 2.49 | 0.51 | 1.13 | -0.15 | 0.15 | 0.09 | |
| Change in Accounts Payable | -4.11 | -2.07 | 2.67 | 4.24 | 3.69 | 2.54 | |
| Change in Other Net Operating Assets | 6.22 | 4.36 | 2.01 | 0.72 | 0.27 | -1.59 | |
| Operating Cash Flow | -30.62 | -41.77 | -32.97 | -31.06 | -24.31 | -20.6 | |
| Long-Term Debt Issued | - | 30 | 30 | 10 | 30 | - | |
| Net Debt Issued (Repaid) | 11 | 30 | 30 | 10 | 30 | - | |
| Issuance of Common Stock | 4.09 | 1.23 | 10.03 | - | 6.81 | 0.26 | |
| Financing Cash Flow | 15.09 | 31.23 | 40.03 | 10 | 36.81 | 0.26 | |
| Net Cash Flow | -15.54 | -10.54 | 7.07 | -21.06 | 12.51 | -20.34 | |
| Levered Free Cash Flow | -24.14 | -28.94 | -20.68 | -17.56 | -13.23 | -11.89 | |
| Unlevered Free Cash Flow | -19.7 | -25.48 | -18.93 | -16.91 | -12.92 | -11.84 | |
| Change in Working Capital | 2.12 | 2.28 | 4.68 | 4.97 | 3.96 | 0.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.